My belief was that the DMD market was supposed to be the company’s “laser focus” over the next 12 months. I certainly gained some comfort from that. To some extent I’d be pretty disappointed if JG started to hang his hat on other diseases such that the can is kicked down the road again in the event trial results stretch.
I think Nottawombat raises some valid concerns Re the timing of DMD trial results. IMO if we were achieving solid enrolment numbers it would have been worthy of an announcement. The Dec quarterly will be due by 31/1 whereupon I hope any slippage in timelines would be advised.
My belief was that the DMD market was supposed to be the...
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $69.41M | |||
| Open | High | Low | Value | Volume |
| 7.7¢ | 7.9¢ | 7.6¢ | $148.9K | 1.895M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 48919 | 7.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 70000 | 1 |
View Market Depth
| Last trade - 15.59pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.8¢ |
Change
0.000 ( 2.63 %) |
||||
| Open | High | Low | Volume | ||
| 7.7¢ | 7.9¢ | 7.7¢ | 43057 | ||
| Last updated 13.04pm 03/05/2024 ? | |||||
| PER (ASX) Chart |